Cargando…

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions

Adverse drug reactions adverse drug reaction (ADR) occur in approximately 17% of patients. Avoiding ADR is thus mandatory from both an ethical and an economic point of view. Whereas, pharmacogenetics changes of the pharmacokinetics may contribute to the explanation of some type A reactions, strong r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böhm, Ruwen, Cascorbi, Ingolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073094/ https://www.ncbi.nlm.nih.gov/pubmed/27818635 http://dx.doi.org/10.3389/fphar.2016.00396

Ejemplares similares

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia
por: Kaehler, Meike, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
por: Zhang, Chunyan, et al.
Publicado: (2021)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions—Potential and Limitations
por: Steiner, Markus, et al.
Publicado: (2016)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
por: Elzagallaai, Abdelbaset A., et al.
Publicado: (2021)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

Hypersensitivity Reactions to Multiple Iodinated Contrast Media
por: Doña, Inmaculada, et al.
Publicado: (2020)

MinION: A Novel Tool for Predicting Drug Hypersensitivity?
por: Chua, Eng Wee, et al.
Publicado: (2016)

Genome-wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor-resistant CML cells
por: Kaehler, Meike, et al.
Publicado: (2022)

Pharmacogenomics in practice: a review and implementation guide
por: Kabbani, Danya, et al.
Publicado: (2023)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
por: Wung, Chih-Hsuan, et al.
Publicado: (2023)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
por: Manson, Lisanne E. N., et al.
Publicado: (2020)

Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions
por: Awortwe, Charles, et al.
Publicado: (2020)

Incidence Rate of Hypersensitivity Reactions to Bee-Venom Acupuncture
por: Lee, Eun-Jung, et al.
Publicado: (2020)

Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018)

LightSNiP assay is a good strategy for pharmacogenetics test
por: Cheli, Stefania, et al.
Publicado: (2015)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
por: Lemke, Lauren K., et al.
Publicado: (2023)

Pharmacogenetics – Challenges and Opportunities Ahead
por: Zanger, Ulrich M.
Publicado: (2010)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy
por: García-Menaya, Jesús Miguel, et al.
Publicado: (2019)

Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations
por: Eum, Seenae, et al.
Publicado: (2016)

In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells
por: Galbiati, Valentina, et al.
Publicado: (2016)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice
por: Martens, Forike K., et al.
Publicado: (2020)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Relevance of G-quadruplex structures to pharmacogenetics
por: Cree, Simone L., et al.
Publicado: (2014)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
por: Wu, Angela, et al.
Publicado: (2023)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

Developmental Pharmacogenetics of CYP2D6 in Chinese Children: Loratadine as a Substrate Drug
por: Li, Qian, et al.
Publicado: (2021)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database
por: Hočevar, Keli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9qtjuuk392d1eavh0lqtgjb7du